Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Acetylcholinesterase (AChE) activity and protein were measured in the CSF of patients with Alzheimer's disease, depression, schizophrenia with and without tardive dyskinesia, and control subjects. AChE activity was assayed by a radioenzymatic method involving the direct extraction of hydrolyzed 3H-acetate into a toluene-based scintillation fluid followed by liquid scintillation spectrometry. AChE activity was proportional to the amount of CSF protein. Greater than 90% of AChE activity in CSF could be inhibited by 10(-3) M eserine. In addition, activity remained stable despite repeated freeze-thawing in an acetone-dry ice bath. Age was found to be positively correlated with CSF protein and AChE activity expressed per volume CSF, but not with AChE measured per milligram protein. No differences between diagnostic groups were found on either measure of AChE when the extraneous factors of age and CSF protein concentrations were controlled, nor were any differences found between groups for CSF protein when age was controlled.
D000110:Acetylcholinesterase / Q000134:cerebrospinal fluid*; D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000201:enzymology*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000032:analysis; D003866:Depressive Disorder / Q000134:cerebrospinal fluid / Q000201:enzymology*; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology*; D006801:Humans; D008875:Middle Aged; D010830:Physostigmine / Q000494:pharmacology; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000201:enzymology*
D002556:Cerebrospinal Fluid Proteins; D002800:Cholinesterase Inhibitors; D010830:Physostigmine; D000110:Acetylcholinesterase